Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Retraction Notice to “Evaluation of the Treatment Strategies on Patient-Derived Xenograft Mice of Human Breast Tumor” [Eur. J. Pharmacol. 889 (2020) 173605] (European Journal of Pharmacology (2020) 889, (S001429992030697x), (10.1016/J.Ejphar.2020.173605))
Ismaeil Haririan
Ismaeil Haririan

Professor of Pharmaceutics

Department Pharmaceutical Biomaterials

School of Pharmacy

Medical Biomaterials Research Center

Tehran University of Medical Sciences

All Documents